Accumulating evidences have revealed that high expression of many traditional checkpoints, such as PDCD1LG2, HAVCR2, and CTLA4, mediated suppression of immune response and ultimately led to immune evasion in GBM (18–25). This evidence concerns the gene PDCD1LG2 and glioblastoma.